75 related articles for article (PubMed ID: 15775628)
1. [Appropriate clinical usage of calcitonin escape phenomenon and intermittent v.s. daily administration of calcitonin].
Wada S; Yasuda S
Clin Calcium; 2001 Sep; 11(9):1169-75. PubMed ID: 15775628
[TBL] [Abstract][Full Text] [Related]
2. Calcitonin receptor regulation and responsiveness to calcitonin in human osteoclast-like cells prepared in vitro using receptor activator of nuclear factor-kappaB ligand and macrophage colony-stimulating factor.
Samura A; Wada S; Suda S; Iitaka M; Katayama S
Endocrinology; 2000 Oct; 141(10):3774-82. PubMed ID: 11014233
[TBL] [Abstract][Full Text] [Related]
3. Expression of the calcitonin receptor, calcitonin receptor-like receptor, and receptor activity modifying proteins during osteoclast differentiation.
Granholm S; Lundberg P; Lerner UH
J Cell Biochem; 2008 Jun; 104(3):920-33. PubMed ID: 18384073
[TBL] [Abstract][Full Text] [Related]
4. Antioxidant alpha-lipoic acid inhibits osteoclast differentiation by reducing nuclear factor-kappaB DNA binding and prevents in vivo bone resorption induced by receptor activator of nuclear factor-kappaB ligand and tumor necrosis factor-alpha.
Kim HJ; Chang EJ; Kim HM; Lee SB; Kim HD; Su Kim G; Kim HH
Free Radic Biol Med; 2006 May; 40(9):1483-93. PubMed ID: 16632109
[TBL] [Abstract][Full Text] [Related]
5. Novel cell-surface Ag expressed on rat osteoclasts regulating the function of the calcitonin receptor.
Kukita T; Kukita A; Nagata K; Maeda H; Kurisu K; Watanabe T; Iijima T
J Immunol; 1994 Dec; 153(11):5265-73. PubMed ID: 7963580
[TBL] [Abstract][Full Text] [Related]
6. Effects of calcitonin on the function of human osteoclast-like cells formed from CD14-positive monocytes.
Yamamoto Y; Yamamoto Y; Udagawa N; Okumura S; Mizoguchi T; Take I; Yamauchi H; Yamauchi H; Noguchi T; Takahashi N
Cell Mol Biol (Noisy-le-grand); 2006 May; 52(3):25-31. PubMed ID: 17535751
[TBL] [Abstract][Full Text] [Related]
7. Attenuation of osteoclastogenesis and osteoclast function by apigenin.
Bandyopadhyay S; Lion JM; Mentaverri R; Ricupero DA; Kamel S; Romero JR; Chattopadhyay N
Biochem Pharmacol; 2006 Jul; 72(2):184-97. PubMed ID: 16750176
[TBL] [Abstract][Full Text] [Related]
8. Physiological levels of calcitonin regulate the mouse osteoclast calcitonin receptor by a protein kinase Alpha-mediated mechanism.
Wada S; Udagawa N; Nagata N; Martin TJ; Findlay DM
Endocrinology; 1996 Jan; 137(1):312-20. PubMed ID: 8536630
[TBL] [Abstract][Full Text] [Related]
9. Mechanism of osteoclast mediated bone resorption--rationale for the design of new therapeutics.
Väänänen K
Adv Drug Deliv Rev; 2005 May; 57(7):959-71. PubMed ID: 15876398
[TBL] [Abstract][Full Text] [Related]
10. 1'-Acetoxychavicol acetate inhibits RANKL-induced osteoclastic differentiation of RAW 264.7 monocytic cells by suppressing nuclear factor-kappaB activation.
Ichikawa H; Murakami A; Aggarwal BB
Mol Cancer Res; 2006 Apr; 4(4):275-81. PubMed ID: 16603641
[TBL] [Abstract][Full Text] [Related]
11. [The molecular mechanism of osteoclastic bone resorption and inhibitory drugs for bone resorption].
Yamamoto Y; Noguchi T; Udagawa N
Clin Calcium; 2005 Jul; 15(7):11-6. PubMed ID: 15995290
[TBL] [Abstract][Full Text] [Related]
12. Bone stromal cells in pagetic bone and Paget's sarcoma express RANKL and support human osteoclast formation.
Sun SG; Lau YS; Itonaga I; Sabokbar A; Athanasou NA
J Pathol; 2006 May; 209(1):114-20. PubMed ID: 16482498
[TBL] [Abstract][Full Text] [Related]
13. [Regulation of osteoclastic function through cell surface receptors].
Kukita T; Kukita A
Clin Calcium; 2003 Apr; 13(4):444-8. PubMed ID: 15775110
[TBL] [Abstract][Full Text] [Related]
14. Receptors of calciotropic hormones.
Findlay DM; Martin TJ
Horm Metab Res; 1997 Mar; 29(3):128-34. PubMed ID: 9137983
[TBL] [Abstract][Full Text] [Related]
15. A novel member of the calcitonin gene-related peptide family, calcitonin receptor-stimulating peptide, inhibits the formation and activity of osteoclasts.
Notoya M; Arai R; Katafuchi T; Minamino N; Hagiwara H
Eur J Pharmacol; 2007 Apr; 560(2-3):234-9. PubMed ID: 17328890
[TBL] [Abstract][Full Text] [Related]
16. Human microvascular endothelial cell activation by IL-1 and TNF-alpha stimulates the adhesion and transendothelial migration of circulating human CD14+ monocytes that develop with RANKL into functional osteoclasts.
Kindle L; Rothe L; Kriss M; Osdoby P; Collin-Osdoby P
J Bone Miner Res; 2006 Feb; 21(2):193-206. PubMed ID: 16418775
[TBL] [Abstract][Full Text] [Related]
17. Identification of a human peripheral blood monocyte subset that differentiates into osteoclasts.
Komano Y; Nanki T; Hayashida K; Taniguchi K; Miyasaka N
Arthritis Res Ther; 2006; 8(5):R152. PubMed ID: 16987426
[TBL] [Abstract][Full Text] [Related]
18. Staphylococcus aureus capsular material promotes osteoclast formation.
Lau YS; Wang W; Sabokbar A; Simpson H; Nair S; Henderson B; Berendt A; Athanasou NA
Injury; 2006 May; 37 Suppl 2():S41-8. PubMed ID: 16651071
[TBL] [Abstract][Full Text] [Related]
19. Differential activity of kaempferol and quercetin in attenuating tumor necrosis factor receptor family signaling in bone cells.
Pang JL; Ricupero DA; Huang S; Fatma N; Singh DP; Romero JR; Chattopadhyay N
Biochem Pharmacol; 2006 Mar; 71(6):818-26. PubMed ID: 16434028
[TBL] [Abstract][Full Text] [Related]
20. Epidermal growth factor receptor regulates osteoclast differentiation and survival through cross-talking with RANK signaling.
Yi T; Lee HL; Cha JH; Ko SI; Kim HJ; Shin HI; Woo KM; Ryoo HM; Kim GS; Baek JH
J Cell Physiol; 2008 Nov; 217(2):409-22. PubMed ID: 18543257
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]